KalVista is advancing science to empower everyday lives. Our mission begins with HAE.

we are bringing a
New perspective
to HAE

At KalVista, we are working to empower people to engage in everyday life beyond the challenges of their disease. With our scientific advances in orally-delivered small molecule medicines, we aim to change the treatment landscape to address the unmet needs of people living with hereditary angioedema (HAE).

About Us

The First and Only
Oral On-demand
Treatment option
for HAE

We are dedicated to pushing beyond the limitations of current therapies to bring patients treatment options that offer new possibilities to manage their disease. Our goal is to make a meaningful difference for people living with HAE.

About HAE

seeing the bigger picture with
One Common
Purpose

Our team of talented professionals and experienced scientists are united in the determination to innovate and elevate the standard of care for patients with a range of diseases, beginning with HAE.

Join our team

Learn about our science

View our pipeline